About Pharma Biotech Consultants | Integrated Clinical & Regulatory Strategy Experts

Advancing Innovation With Purpose

Pharma Biotech Consultants was founded by industry veterans with a shared mission: to accelerate the development of innovative therapies and bring meaningful healthcare solutions to patients worldwide.

$20b+

More than $20 billions USD were generated after approvals of the development programs we were leading

25+

approved NCEs, new labels and line extensions

Pharma Biotech Consultants - New York - New Jersey

Meet our managing team

Marie-Louise Jacques, M.D., M.B.A.

Chief Executive Officer & Founder

E: mljacques@pharmabiotechconsultants.net

L: @malou-jacques

Christian Jacques, M.D.

Chief Scientific Officer & Founder

E: chjacques@pharmabiotechconsultants.net

L: @christian-jacques

Pharma Biotech Consultants - Malou Jacques

Marie-Louise Jacques, M.D., M.B.A.

Chief Executive Officer & Co-Founder

E: mljacques@pharmabiotechconsultants.net

L: @malou-jacques

A global biopharmaceutical leader with more than 30 years of experience in clinical development, regulatory strategy, medical affairs, and pharmaco-economics.

She has led major programs in ophthalmology, cardiology, neurology and critical care, and has secured multiple global approvals across the U.S., Europe, and Asia.

Christian Jacques, M.D., M.Sc.

Chief Scientific Officer & Co-Founder

E: chjacques@pharmabiotechconsultants.net

L: @christian-jacques

A senior Hemato-Oncologist with 10 years of clinical experience and 30 years of drug development in hematology, oncology, and immunotherapy, along with six approvals of paradigm-shifting therapies.

Pharma Biotech Consultants - Christian Jacques

Discovery and Assessment

The journey begins with proactive search for promising medical research projects. Our team conducts a thorough assessment, evaluating each project's innovation, potential impact, and feasibility. This involves rigorous scientific review, potential market analysis, and preliminary discussions with research teams to understand their vision, capabilities, and needs.

Due Diligence and Selection

Following initial assessments, selected projects undergo a comprehensive due diligence process. This step digs deeper into the project's technical details, team qualifications, legal considerations, and financial requirements. It ensures that only the most viable and impactful projects are chosen for funding, aligning with Stem's mission to accelerate the development of transformative healthcare solutions.

Matching with Investors

Once a project passes our stringent evaluation process, Stem matches it with suitable investors from our network. This matchmaking is based on the project's specific needs and the investor's interest areas and investment philosophy. Our aim is to create synergistic partnerships that provide not just financial support but also strategic value to propel the research forward.

Related expertise

Our integrated approach brings together specialized expertise across every dimension of drug development. Each area reinforces the next, ensuring your project advances with consistency and precision.

Clinical development and medical affairs
Regulatory strategy and submissions
Pharmaco-economics and market access
Safety analytics and data mining
Business and portfolio strategy
Due diligence

Let’s design your integrated development plan.

About us

Meet our managing team

Our Process

Related expertise